KUWAIT DRUGS

 

SEARCH

 

SUGGESTIONS

 

ADD PRODUCTS

 

HOME

0-9    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

 

 

PREVIOUS

  

NEXT

 
 

VANCOLED 500 MG VIALS

 

 
 

 

GENERIC NAMES

MANUFACTURERS 

MEDICAL GROUP

MEDICAL ARTICLES

 

DRUGS IN :

 

 

FDA DRUGS

UNITED STATES

CANADA

UNITED KINGDOM

AUSTRALIA

GERMANY

FRANCE

MIDDLE EAST

KUWAIT

LEBANON

EGYPT

SYRIA

BAHRAIN

IRAN

JORDAN

SAUDI ARABIA

UNITED ARAB EMIRATES

 

 

 
 

SIZE:

500 MG

 

GENERIC NAME:

VANCOMYCIN HYDROCHLORIDE

 

MANUFACTURER:

LEDERLE LABORATORIES

 

UNIT:

 

ADMINISTRATION ROUTE:

 

FDA PREGNANCY GROUP:

C

 

INDICATIONS:

Colitis, pseudomembranous

Endocarditis

Enterocolitis

Infection, bone

Infection, lower respiratory tract

Infection, skin and skin structure

Septicemia

 

SIDE EFFECTS:

difficulty in breathing

drowsiness

fever

increased thirst

loss of appetite

loss of hearing

nausea or vomiting

ringing or buzzing or a feeling of fullness in the ears

weakness

Nephrotoxicity

neutropenia

"red man syndrome"

Chemical peritonitis

linear IgA bullous dermatosis

ototoxicity

pseudomembranous colitis

thrombocytopenia

Abdominal or stomach cramps and pain, severe

abdominal tenderness

change in frequency of urination or amount of urine

diarrhea, watery and severe, which may also be bloody

 

ABSOLUTE CONTRAINDICATIONS :

 

RELATIVE CONTRAINDICATIONS :

Hypersensitivity to vancomycin

>> Loss of hearing, or deafness

>> Renal function impairment

 

ADULT DOSE:

Antibacterial, treatment- Intravenous infusion, 7.5 mg (base) per kg of body weight or 500 mg every six hours; or 15 mg per kg of body weight or 1 gram every twelve hours . Note: After an initial loading dose of 750 mg to 1 gram (base), but not less than 15 mg per kg of body weight, adults with impaired renal function may require a reduction in dose as indicated in the table below. However, the preferred method is to adjust dosage based on serum vancomycin concentrations. Creatinine clearance (mL/min)/(mL/sec) Intravenous dose (base) > 80/1.33 See 50-80/0.83-1.33 1 gram every 1 to 3 days 10-50/0.17-0.83 1 gram every 3 to 7 days < 10/0.17 1 gram every 7 to 14 days [Endocarditis, prophylaxis, in penicillin-allergic patients with prosthetic heart valves or congenital, rheumatic, or other acquired valvular heart disease who are undergoing gastrointestinal or genitourinary tract procedures] - Intravenous infusion, 1 gram (base) over a period of one to two hours, with or without gentamicin (administered intramuscularly or intravenously at a dose of 1.5 mg per kg of body weight up to 120 mg), depending on risk of bacterial endocarditis; the infusion/injection should be completed within one-half hour of the start of surgery .

 

MAXIMUM ADULT DOSE:

3 to 4 grams (base) a day have been used intravenously for short periods of time in very severe infections.

 

PEDIATRIC DOSE:

Antibacterial, treatment- Neonates up to 1 week of age: Intravenous infusion, 15 mg (base) per kg of body weight initially, followed by 10 mg per kg of body weight every twelve hours . Infants 1 week to 1 month of age: Intravenous infusion, 15 mg (base) per kg of body weight initially, followed by 10 mg per kg of body weight every eight hours . Infants and children 1 month to 12 years of age: Intravenous infusion, 10 mg (base) per kg of body weight every six hours ; or 20 mg per kg of body weight every twelve hours. Note: Doses of up to 60 mg (base) per kg of body weight per day have been used in some infections (e.g., staphylococcal infections of the central nervous system [CNS]). [Endocarditis, prophylaxis, in penicillin-allergic patients with prosthetic heart valves or congenital, rheumatic, or other acquired valvular heart disease who are undergoing gastrointestinal or genitourinary tract procedures] - Intravenous infusion, 20 mg (base) per kg of body weight over a period of one to two hours, with or without gentamicin (administered intramuscularly or intravenously at a dose of 1.5 mg per kg of body weight), depending on degree of risk; the infusion/injection should be completed within one-half hour of the start of surgery . 

 

MAXIMUM PEDIATRIC DOSE:

 

ELDERLY DOSE:

 

 

PREVIOUS

  

NEXT